Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -11.92% is 51% above its 5-year average of -24.58%, near the high end of its 5-year range (-82.17%–-11.92%).
As of the fiscal period ended Tuesday, June 30, 2026. 46.72% above its 12-month average of -22.38%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -11.92%.
RETURN ON EQUITY (ROE)
-11.92%
RETURN ON EQUITY (ROE) AVG TTM
-22.38%
RETURN ON EQUITY (ROE) AVG 3Y
-20.09%
RETURN ON EQUITY (ROE) AVG 5Y
-24.58%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+46.72%
CURRENT VS 3Y AVG
+40.64%
CURRENT VS 5Y AVG
+51.49%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+71.62%
vs the sector median at left
Oruka Therapeutics, Inc.
Market Cap
$4.82B
Return on Equity (ROE)
-11.92%
TTM Avg
-22.38%
3Y Avg
-20.09%
5Y Avg
-24.58%
Market Cap
$4.79B
Return on Equity (ROE)
N/A
TTM Avg
-23.20%
3Y Avg
-51.91%
5Y Avg
-56.25%
Market Cap
$4.71B
Return on Equity (ROE)
-2.55%
TTM Avg
-28.50%
3Y Avg
-30.36%
5Y Avg
-30.19%
Market Cap
$4.70B
Return on Equity (ROE)
6.24%
TTM Avg
-11.62%
3Y Avg
-98.18%
5Y Avg
-98.18%
Market Cap
$4.68B
Return on Equity (ROE)
3.43%
TTM Avg
-1.67%
3Y Avg
-7.64%
5Y Avg
-9.04%
Market Cap
$4.68B
Return on Equity (ROE)
-38.51%
TTM Avg
-50.16%
3Y Avg
-65.11%
5Y Avg
-61.13%
Market Cap
$4.66B
Return on Equity (ROE)
16.63%
TTM Avg
15.37%
3Y Avg
15.09%
5Y Avg
11.91%
Market Cap
$5.00B
Return on Equity (ROE)
-79.37%
TTM Avg
-38.23%
3Y Avg
-43.73%
5Y Avg
-49.41%
Market Cap
$5.03B
Return on Equity (ROE)
3.38%
TTM Avg
1.14%
3Y Avg
-0.67%
5Y Avg
-0.98%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | $4.82B | -11.92% | -22.38% | -20.09% | -24.58% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.79B | N/A | -23.20% | -51.91% | -56.25% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.71B | -2.55% | -28.50% | -30.36% | -30.19% |
| BillionToOne, Inc. (BLLN)vs › | $4.70B | 6.24% | -11.62% | -98.18% | -98.18% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 3.43% | -1.67% | -7.64% | -9.04% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.68B | -38.51% | -50.16% | -65.11% | -61.13% |
| Option Care Health, Inc. (OPCH)vs › | $4.66B | 16.63% | 15.37% | 15.09% | 11.91% |
| Erasca, Inc. (ERAS)vs › | $5.00B | -79.37% | -38.23% | -43.73% | -49.41% |
| Waystar Holding Corp. (WAY)vs › | $5.03B | 3.38% | 1.14% | -0.67% | -0.98% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.07B | -161.00% | -110.38% | -86.51% | -75.97% |
ROE
-11.9%
ROA
-11.7%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -11.92% |
| 2026-03-31 | -23.89% |
| 2025-12-31 | -22.34% |
| 2025-09-30 | -22.44% |
| 2025-06-30 | -31.31% |
| 2025-03-31 | -28.86% |
| 2024-12-31 | -22.57% |
| 2024-09-30 | -15.76% |
| 2024-06-30 | -82.17% |
| 2024-03-31 | -17.09% |
| 2023-12-31 | -14.42% |
| 2023-09-30 | -14.29% |
| 2023-06-30 | -16.14% |
| 2023-03-31 | -19.74% |
| 2022-12-31 | -23.82% |
| 2022-09-30 | -33.77% |
| 2022-06-30 | -37.38% |
| 2022-03-31 | -38.58% |
| 2021-12-31 | -37.85% |
| 2021-09-30 | -33.16% |
| 2021-06-30 | -26.22% |
| 2021-03-31 | -18.99% |
| 2020-12-31 | -20.93% |
| 2020-09-30 | -11.57% |
| 2020-06-30 | -48.56% |
| 2020-03-31 | -81.48% |
| 2019-12-31 | -72.04% |
| 2019-09-30 | -65.29% |
| 2019-06-30 | -67.28% |
| 2019-03-31 | -93.77% |
| 2018-12-31 | -131.52% |
| 2018-09-30 | -142.58% |
| 2018-06-30 | -149.82% |
| 2018-03-31 | -152.77% |
| 2017-12-31 | -179.95% |
